IGM Biosciences Inc (IGMS)
10.35
-0.87
(-7.75%)
USD |
NASDAQ |
Nov 14, 13:12
IGM Biosciences Debt to Equity Ratio: 0.00 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
June 30, 2024 | 0.00 |
March 31, 2024 | 0.00 |
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
Date | Value |
---|---|
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2022
--
Maximum
Jun 2022
--
Average
--
Median
Jun 2022
Debt to Equity Ratio Benchmarks
Moderna Inc | 0.00 |
NovaBay Pharmaceuticals Inc | -1.128 |
Palatin Technologies Inc | 0.00 |
iBio Inc | 0.0461 |
Theriva Biologics Inc | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 336.50M |
Total Liabilities (Quarterly) | 214.14M |
Shareholders Equity (Quarterly) | 122.36M |
Current Ratio | 7.065 |